L3VLUP
ProSign in

IART · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

IARTLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • IART
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterIARTLLY
Q3 20206 holders, $992m33 holders, $14.1bn
Q4 20206 holders, $1.4bn29 holders, $17.3bn
Q1 20214 holders, $1.5bn24 holders, $23.0bn
Q2 20216 holders, $1.5bn24 holders, $27.8bn
Q3 20216 holders, $1.7bn31 holders, $29.9bn
Q4 20216 holders, $1.6bn31 holders, $34.7bn
Q1 20228 holders, $1.3bn24 holders, $35.3bn
Q2 202210 holders, $969m33 holders, $42.7bn
Q3 202214 holders, $702m31 holders, $43.4bn
Q4 202211 holders, $946m31 holders, $46.6bn
Q1 202311 holders, $864m33 holders, $44.3bn
Q2 202312 holders, $492m37 holders, $59.6bn
Q3 202313 holders, $481m44 holders, $67.6bn
Q4 202310 holders, $530m45 holders, $73.6bn
Q1 20248 holders, $378m41 holders, $95.3bn
Q2 20246 holders, $212m43 holders, $110bn
Q3 20243 holders, $87m45 holders, $107bn
Q4 20243 holders, $60m46 holders, $93.9bn
Q1 20253 holders, $34m42 holders, $98.4bn
Q2 20252 holders, $2.8m43 holders, $93.2bn
Q3 20252 holders, $1.8m39 holders, $86.7bn
Q4 20251 holders, $662k41 holders, $123bn
Q1 20261 holders, $679k39 holders, $106bn
Q2 20261 holders, $1.8m44 holders, $132bn
IART

Integra Lifesciences Holdings Corp

Holders
2
Reported value
$2.8m
Buyers
1
Sellers
2

Breadth -1 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
43
Reported value
$93.2bn
Buyers
25
Sellers
22

Breadth +3 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 44 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only IART (1)

Winton Group Ltd

Only LLY (42)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Maverick Capital Ltd, and 17 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →